Skip to content
Chromogenics
The performance glass pioneers
ChromogenicsChromogenics
  • Products
  • Cases
  • Environment & Quality
    • Environment
    • Quality
  • News & press
    • News
    • Press Releases
  • About us
    • Career
    • Contact
    • Invoicing
    • Presentations
    • Sputter Factory
  • For Investors
  • Swedish
  • English
Search:
  • Products
  • Cases
  • Environment & Quality
    • Environment
    • Quality
  • News & press
    • News
    • Press Releases
  • About us
    • Career
    • Contact
    • Invoicing
    • Presentations
    • Sputter Factory
  • For Investors

ChromoGenics AB (publ) Rights Issue January - February 2019

Briefly about ChromoGenics

ChromoGenics offers dynamic, built-in solar control for windows and facade glass. ConverLight adapts the light transmittance for maximum comfort and energy efficiency. I-Window is a world class static solar protection glass at a competitive price.

The four most important driving forces at ChromoGenics:

  • Indoor comfort: Block out unwanted sunlight and heat while keeping the view.
  • Design: Full architectural freedom for facades without awnings and blinds.
  • Energy efficiency: Significantly less need for air conditioning – which according to the Economist is one of the major environmental culprits of our time.
  • Price: Glasses with integrated solar control are more cost effective than the other alternatives over time.
Collage of the exterior and interior of Holmøy Maritime AS

KONTOR SORTLAND, NORGE Holmøy Maritime AS 239 m2 | ConverLight®

  • Download the information brochure here
  • Download the Prospectus here
  • Download the additional Prospectus here
  • Download the application form here
  • Download the press release about Prospectus regarding Rights Issue here
  • Download the Communiqué from the extra general meeting here
  • Download the auditors statement on the Board’s report on significant events in accordance with ch. Section 6 of the Swedish Companies Act (2005 551) here
  • Download the press release The Board’s decision about the Rights Issue here

Terms for the Rights Issue in summary

Issue amount at full subscription
77,7 MSEK

Subscriptions and warranty commitments
Subscription commitments of approximately 1,7 MSEK and warranty commitments of approximately 58,9 MSEK have been entered into, which corresponds to approximately 78% of 77,7 MSEK. However, the company has neither requested nor received bank collateral for these commitments.

Preference rights and unit rights
Anyone who was registered as a shareholder at the record date January 24th of 2019 has preference rights to subscribe for shares in the Rights Issue and will receive three (3) subscription rights for each share held. One (1) subscription right entitles to subscription of one (1) share. In addition, shareholders and other investors are being offered without preferential right to register an interest in subscribing for new shares.

Subscription without precedence
Subscription without precedence takes place by a special application form or electronically via www.aktieinvest.se/chromogenics2019. If you want to invoke priority and your shareholding is nominee-registered, subscription must take place in accordance with your nominee’s routines.

Subscription course
0,60 SEK per share

Subscription time
28th – 15th of February 2019

Trade with subscription rights
28th – 13th of February 2019

Trade with BTA
January 28, 2019 until later dates announced in connection with the registration of the issue.

ISIN-codes at Nasdaq First North
Share – CHRO SE0009496268
Subscription right – CHRO TR SE0012194454
Paid subscription share – CHRO BTA SE0012194462

Documents incorporated by reference

The Company’s interim report for January – September 2018, including the audit reports for the Company’s year-end reports for the financial years of 2016 and 2017, forms a part of the Prospectus and should be read as part of this. Download these documents here

Documents available for inspection

The following documents are available for inspection at the Company’s office (Ullforsgatan 15, 752 28 Uppsala) as well as in electronic form at the Company’s website (www.chromogenics.com). Copies can be obtained from or reviewed at the office during regular office hours on weekdays throughout the Prospectus’ validity period:

  • Registration certificate
  • Memorandum of association
  • Articles of Association for ChromoGenics AB (publ)
  • ChromoGenics AB (publ) audited accounts for the financial year of 2017, including the auditor’s report
  • ChromoGenics AB (publ) audited accounts for the financial year of 2016, including the auditor’s report
Contact us

For Investors

Financial Calendar

Financial Reports

  • Interim Reports
  • Annual Reports

Presentations

Press Releases

Corporate Governance

  • General Meetings
  • Articles of Association
  • Board of Directors
  • Management
  • Nomination Committee
  • Auditor
  • Certified Adviser

Share Information

Rights Issues

  • Warrants of series TO6 2023 November
  • Rights Issue 2023 June
  • Warrants of series TO4 and TO5 2023 March
  • Rights Issue 2022 November
  • Rights Issue 2022 February – March
  • Rights Issue 2020 November – December
  • Rights Issue 2020 February – March
  • Rights Issue 2019 June – July
  • Rights Issue 2019 January – February
  • Rights Issue 2018

IPO

Glossary

IR Contact
Anne-Marie Gullman

CFO & Head of Investor Relations

E-mail
Follow us

Follow us on social media to stay updated on what´s happening at ChromoGenics

ChromoGenicswhitelogo
  • Swedish
  • English
Contact

info@chromogenics.com

+46 18 430 04 30

Ullforsgatan 15

SE-75228 Uppsala, Sweden
ChromoGenics
  • About us
  • Contact
  • ConverLight
  • For Investors
  • Press Releases
Follow us

Find us on:

Facebook page opens in new windowX page opens in new windowLinkedin page opens in new windowInstagram page opens in new window

ChromoGenics develops smart dynamic glass (electrochromic glazing) for buildings and façades under the brand ConverLight®, offering energy efficiency and solar control.

Chromogenics
© ChromoGenics 2025 | Cookies & Privacy Notice
Go to Top
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept”, you consent to the use of ALL the cookies.
Read More Cookie settingsACCEPT
Manage consent

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
SAVE & ACCEPT